Brief: Biogen Expects Total Rev To Increase By A Mid-Single Digit Percentage For 2026
BRIEF-Biogen Expects Total Rev To Increase By A Mid-Single Digit Percentage For 2026 Oct 28 (Reuters) - Biogen Inc. BIIB.O:
BIOGEN Q3 REVENUE $2.80 BILLION VERSUS IBES ESTIMATE $2.63 BILLION
BIOGEN OUTLOOK FY ADJUSTED EPS $12.20 TO $13.00 VERSUS IBES ESTIMATE $12.36
BIOGEN Q3 ADJUSTED EPS $2.62 VERSUS IBES ESTIMATE $1.99
BIOGEN: Q3 LEQEMBI IN-MARKET REVENUE $202 MILLION
BIOGEN: TOTAL REVENUE EXPECTED TO INCREASE BY A MID-SINGLE DIGIT PERCENTAGE FOR 2026
BIOGEN INC. FY2026 REVENUE VIEW $10.45 BILLION -- IBES DATA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biogen
See all newsUS RESEARCH ROUNDUP-Autodesk, Metlife, Rollins
Brief: Biogen Says DZP Plus Soc Meets Primary Endpoint Of BICLA Response At Week 48
Brief: Biogen Provides Update On Private Payer Coverage For Zurzuvae™ (Zuranolone)
US RESEARCH ROUNDUP-Eli Lilly, General Dynamics, S&P Global
US RESEARCH ROUNDUP-Baker Hughes, Brinker International, GE Vernova